DOCSLIB.ORG

Mitosis-Mediated Intravasation in a Tissue-Engineered Tumor−Microvessel Platform

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mitosis-Mediated Intravasation in a Tissue-Engineered Tumor−Microvessel Platform Published OnlineFirst September 18, 2017; DOI: 10.1158/0008-5472.CAN-16-3279 Cancer Integrated Systems and Technologies Research Mitosis-Mediated Intravasation in a Tissue- Engineered Tumor–Microvessel Platform Andrew D. Wong1,2 and Peter C. Searson1,2,3 Abstract Intravasation involves the migration of tumor cells across the cell interactions with functional microvessels and provide evi- local endothelium and escape into vessel flow. Although tumor dence for a mitosis-mediated mechanism where tumor cells cell invasiveness has been correlated to increased intravasation, located along the vessel periphery are able to disrupt the vessel the details of transendothelial migration and detachment into endothelium through cell division and detach into circulation. circulation are still unclear. Here, we analyzed the intravasation of This model provides a framework for understanding the physical invasive human breast cancer cells within a tissue-engineered and biological parameters of the tumor microenvironment microvessel model of the tumor microenvironment. Using live- that mediate intravasation of tumor cells across an intact endo- cell fluorescence microscopy, we captured 2,330 hours of tumor thelium. Cancer Res; 77(22); 1–9. Ó2017 AACR. Introduction without the assistance of TAMs (5, 9, 10). These studies suggest that there are multiple pathways for intravasation, but the lack of Metastasis involves a sequence of steps including invasion, sufficient resolution has hampered our understanding of the intravasation, circulation, arrest, and extravasation that ultimately mechanism of tumor cell transendothelial migration (TEM) and result in tumor cell dormancy and/or growth at a secondary site detachment into circulation. (1). Intravasation, the entry of tumor cells into circulation, is a Recent advances in the development of in vitro microvessel critical step that occurs at both primary and secondary tumor sites models provide the tools to recreate the essential components of (2). The discovery of circulating tumor cells years after primary the tumor microenvironment and enable visualization of the treatment reveals that tumor cells continue to spread through the details of the metastatic cascade (11–13). Here we set out to vasculature and is a negative prognostic indication for cancer investigate the mechanism of intravasation of BCCs and to relapse (2, 3). Reducing intravasation may ultimately improve address the question, how do tumor cells cross endothelial junc- patient outcome; however, the details of these events are difficult tions to enter circulation? Using live-cell imaging in a tissue- to resolve, as it is a dynamic process that occurs at the interface engineered microvessel model of the tumor microenvironment, between tumor cells and the local tumor microvasculature. we analyzed over 2,330 hours of tumor cell interactions with Our understanding of the dynamics of intravasation is derived functional microvessels and found that intravasation events were largely from a relatively small number of intravital microscopy rare but predominately associated with mitosis. We quantified the (IVM) studies and few direct observations at the single cell level. deflection of peripheral tumor cells on the vessel endothelium For example, intravasation has been investigated in zebrafish and and provide evidence for a model where mitotic single-cell round- chick embryos (4, 5), but only directly observed in mouse models ing exerts a force on the endothelium that is sufficiently large to (6, 7). From these studies, we have learned that tumor associated transiently open endothelial cell–cell junctions and expose the macrophages (TAM) enhance the invasion of breast cancer cells tumor cells to shear flow, which pulls the daughter cells into (BCC) towards vessels through EGF and CSF1 chemotaxis (6, 8) circulation. To confirm that this is the dominant mechanism of and local expression of VEGF causes downregulation of endo- intravasation, we showed that tumor cells that extended protru- thelial cell–cell junctions, thus increasing the intravasation fre- sions across the interface did not intravasate. Similarly, tumor quency. However, tumor cells oversecreting growth factors are cells dividing in a larger perivascular space were unable to deflect also capable of intravasation across multiple in vivo systems the vessel endothelium and intravasate. These results demonstrate a simple, yet effective mechanism by which single tumor cells may undergo intravasation and provide a framework for understand- 1Institute for Nanobiotechnology, Johns Hopkins University, Baltimore, Mary- land. 2Department of Materials Science and Engineering, Johns Hopkins Uni- ing the physical and biological parameters that enable intravasa- versity, Baltimore, Maryland. 3Department of Oncology, Johns Hopkins Univer- tion through this pathway. sity School of Medicine, Baltimore, Maryland. Note: Supplementary data for this article are available at Cancer Research Materials and Methods Online (http://cancerres.aacrjournals.org/). Device fabrication Corresponding Author: Peter C. Searson, Johns Hopkins University, 100 Croft The tumor-microvessel platform was fabricated as described Hall, 3400 North Charles Street, Baltimore, MD 21218. Phone: 410-516-8774; previously (13). Briefly, high concentration rat tail collagen type I Fax: 410-516-5293; E-mail: [email protected] (Corning Inc.) is diluted to 7 mg/mL and neutralized with the doi: 10.1158/0008-5472.CAN-16-3279 manufacturer's recommended amounts of DI water, 10Â PBS, Ó2017 American Association for Cancer Research. and 1 N sodium hydroxide. After neutralization, tumor cells are www.aacrjournals.org OF1 Downloaded from cancerres.aacrjournals.org on September 23, 2021. © 2017 American Association for Cancer Research. Published OnlineFirst September 18, 2017; DOI: 10.1158/0008-5472.CAN-16-3279 Wong and Searson introduced into the collagen solution to a final concentration of donkey anti-mouse IgG (H þ L) antibody conjugated to Alexa 5 Â 105 cells/mL and injected around a cylindrical template rod Fluor 647 (A31571; Thermo Fisher Scientific) was incubated for (diameter 150 mm) within the polydimethyl siloxane (PDMS) 1 hour. Cells were washed for 10 minutes, three times between housing of the platform (Supplementary Fig. S1). After collagen fixing and incubation steps with PBS. gelation at room temperature, the rod is removed, leaving behind a cylindrical channel within the collagen gel. The channel is Image analysis fi m subsequently coated with bronectin (50 g/mL) to promote Intravasating tumor cells located at the ECM–vessel interface endothelial adhesion and spreading. Endothelial cells in along the middle of the vessel (i.e., vessel equator) were manually suspension are introduced into the channel at a concentration traced in ImageJ (NIH, Bethesda, MD) at each time-lapse frame. Â 6 of 5 10 cells/mL and allowed to settle and actively adhere to the Tumor cell circularity (i.e., shape factor, 4ÁpÁarea/perimeter2) was channel walls. After the endothelial cells have spread for about calculated as well as the maximum cell width perpendicular to the 2 hours, normal growth media (NGM) is perfused through the vessel wall. The latter was obtained by measuring the widths along < 2 vessel at a low applied shear stress ( 1 dyne/cm ) overnight. the entire length of tumor cell perpendicular to the vessel wall and fl Devices were typically con uent after 1 day and were switched to taking the maximum value with a custom written ImageJ plugin 2 higher shear stress ( 4 dyne/cm ) conditions for at least 24 hours (program provided in Supplementary Materials). These values before live-cell imaging. were plotted versus time. Cell motility descriptors (e.g., persis- tence, RMS speed, and directedness) were measured for tumor Cell lines and culture conditions cells located at the interface (n ¼ 38 cells continuously tracked for Human umbilical vein endothelial cells (HUVEC; Promocell), 12–17 hours from 4 independent microvessels) as well as in the human dermal microvascular endothelial cells (HMVEC; Lonza), bulk ECM (n ¼ 35 cells continuously tracked for 12–18 hours and VeraVec HUVEC-TURBOGFP (HVERA-GFP; Catalog. No. from 7 independent microvessels). Cell locations were approxi- HVERA-UMB-202100; Angiocrine Bioscience) were seeded in the mated in ImageJ from time-lapse images by manually tracing the cylindrical channel of the microvessel platform. Endothelial cells nucleus of each tumor cell every hour. Only data from tumor cells were grown in MCDB 131 (Caisson Labs) supplemented with tracked for a minimum of 12 hours were used, which reduced the 10% heat inactivated FBS (Sigma), 25 mg/mL endothelial mito- variance of each cell's average RMS speed, persistence, and direct- gen (BT-203, Biomedical Technologies), 2 U/mL herparin edness. Persistence is the shortest length connecting the start-to- m (Sigma), 1 g/mL hydrocortisone (Sigma), 0.2 mmol/L ascorbic end distance divided by the total path length acquired over the – – acid 2-phosphate (Sigma), and 1% penicillin streptomycin glu- entire duration of cell tracking. An average RMS speed for each tamine (Life Technologies). Dual-labeled MDA-MB-231 BCCs tumor cell was obtained by averaging the displacement over time (AntiCancer Inc.) were embedded within the collagen type I ECM for each one hour segment of a tumor cell's migration; for around the microvessel (14). Cancer cells were grown in RPMI example, a tumor cell tracked for 12 hours will exhibit 12 – (Corning Inc.) supplemented with 10% FBS and 1% penicillin individual
Load more

Recommended publications
  • And MMP-Mediated Cell–Matrix Interactions in the Tumor Microenvironment
    International Journal of Molecular Sciences Review Hold on or Cut? Integrin- and MMP-Mediated Cell–Matrix Interactions in the Tumor Microenvironment Stephan Niland and Johannes A. Eble * Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, 48149 Münster, Germany; [email protected] * Correspondence: [email protected] Abstract: The tumor microenvironment (TME) has become the focus of interest in cancer research and treatment. It includes the extracellular matrix (ECM) and ECM-modifying enzymes that are secreted by cancer and neighboring cells. The ECM serves both to anchor the tumor cells embedded in it and as a means of communication between the various cellular and non-cellular components of the TME. The cells of the TME modify their surrounding cancer-characteristic ECM. This in turn provides feedback to them via cellular receptors, thereby regulating, together with cytokines and exosomes, differentiation processes as well as tumor progression and spread. Matrix remodeling is accomplished by altering the repertoire of ECM components and by biophysical changes in stiffness and tension caused by ECM-crosslinking and ECM-degrading enzymes, in particular matrix metalloproteinases (MMPs). These can degrade ECM barriers or, by partial proteolysis, release soluble ECM fragments called matrikines, which influence cells inside and outside the TME. This review examines the changes in the ECM of the TME and the interaction between cells and the ECM, with a particular focus on MMPs. Keywords: tumor microenvironment; extracellular matrix; integrins; matrix metalloproteinases; matrikines Citation: Niland, S.; Eble, J.A. Hold on or Cut? Integrin- and MMP-Mediated Cell–Matrix 1. Introduction Interactions in the Tumor Microenvironment.
    [Show full text]
  • Metadherin Functions As a Laminin Receptor That Is Essential for Metastasis and Is Associated with Poor Survival in Osteosarcoma
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 5-2014 METADHERIN FUNCTIONS AS A LAMININ RECEPTOR THAT IS ESSENTIAL FOR METASTASIS AND IS ASSOCIATED WITH POOR SURVIVAL IN OSTEOSARCOMA Limin Zhu Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Cancer Biology Commons Recommended Citation Zhu, Limin, "METADHERIN FUNCTIONS AS A LAMININ RECEPTOR THAT IS ESSENTIAL FOR METASTASIS AND IS ASSOCIATED WITH POOR SURVIVAL IN OSTEOSARCOMA" (2014). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 448. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/448 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. METADHERIN FUNCTIONS AS A LAMININ RECEPTOR THAT IS ESSENTIAL FOR METASTASIS AND IS ASSOCIATED WITH POOR SURVIVAL IN OSTEOSARCOMA
    [Show full text]
  • The Urokinase Receptor: a Multifunctional Receptor in Cancer Cell Biology
    International Journal of Molecular Sciences Review The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications Anna Li Santi 1,†, Filomena Napolitano 2,†, Nunzia Montuori 2 and Pia Ragno 1,* 1 Department of Chemistry and Biology, University of Salerno, Fisciano, 84084 Salerno, Italy; [email protected] 2 Department of Translational Medical Sciences, “Federico II” University, 80135 Naples, Italy; fi[email protected] (F.N.); [email protected] (N.M.) * Correspondence: [email protected] † Equal contribution. Abstract: Proteolysis is a key event in several biological processes; proteolysis must be tightly con- trolled because its improper activation leads to dramatic consequences. Deregulation of proteolytic activity characterizes many pathological conditions, including cancer. The plasminogen activation (PA) system plays a key role in cancer; it includes the serine-protease urokinase-type plasminogen activator (uPA). uPA binds to a specific cellular receptor (uPAR), which concentrates proteolytic activity at the cell surface, thus supporting cell migration. However, a large body of evidence clearly showed uPAR involvement in the biology of cancer cell independently of the proteolytic activity of its ligand. In this review we will first describe this multifunctional molecule and then we will discuss how uPAR can sustain most of cancer hallmarks, which represent the biological capabilities acquired during the multistep cancer development. Finally, we will illustrate the main data available in the literature on uPAR as a cancer biomarker and a molecular target in anti-cancer therapy. Citation: Li Santi, A.; Napolitano, F.; Montuori, N.; Ragno, P. The Keywords: urokinase receptor; uPAR; cancer hallmarks Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology.
    [Show full text]
  • The Basics of Epithelial-Mesenchymal Transition
    Amendment history: Corrigendum (May 2010) The basics of epithelial-mesenchymal transition Raghu Kalluri, Robert A. Weinberg J Clin Invest. 2009;119(6):1420-1428. https://doi.org/10.1172/JCI39104. Review Series The origins of the mesenchymal cells participating in tissue repair and pathological processes, notably tissue fibrosis, tumor invasiveness, and metastasis, are poorly understood. However, emerging evidence suggests that epithelial- mesenchymal transitions (EMTs) represent one important source of these cells. As we discuss here, processes similar to the EMTs associated with embryo implantation, embryogenesis, and organ development are appropriated and subverted by chronically inflamed tissues and neoplasias. The identification of the signaling pathways that lead to activation of EMT programs during these disease processes is providing new insights into the plasticity of cellular phenotypes and possible therapeutic interventions. Find the latest version: https://jci.me/39104/pdf Review series The basics of epithelial-mesenchymal transition Raghu Kalluri1,2 and Robert A. Weinberg3 1Division of Matrix Biology, Beth Israel Deaconess Medical Center, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA. 2Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts, USA. 3Whitehead Institute for Biomedical Research, Ludwig Center for Molecular Oncology, and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. The origins of the mesenchymal cells participating in tissue repair and pathological processes, notably tissue fibro- sis, tumor invasiveness, and metastasis, are poorly understood. However, emerging evidence suggests that epithe- lial-mesenchymal transitions (EMTs) represent one important source of these cells. As we discuss here, processes similar to the EMTs associated with embryo implantation, embryogenesis, and organ development are appropri- ated and subverted by chronically inflamed tissues and neoplasias.
    [Show full text]
  • Dentinogenic Effects of Extracted Dentin Matrix Components Digested with Matrix Metalloproteinases
    www.nature.com/scientificreports There are amendments to this paper OPEN Dentinogenic efects of extracted dentin matrix components digested with matrix metalloproteinases Received: 10 April 2017 Motoki Okamoto1, Yusuke Takahashi1, Shungo Komichi1, Paul R. Cooper2 & Mikako Hayashi1 Accepted: 5 July 2018 Dentin is primarily composed of hydroxyapatite crystals within a rich organic matrix. The organic Published: xx xx xxxx matrix comprises collagenous structural components, within which a variety of bioactive molecules are sequestered. During caries progression, dentin is degraded by acids and enzymes derived from various sources, which can release bioactive molecules with potential reparative activity towards the dentin-pulp complex. While these molecules’ repair activities in other tissues are already known, their biological efects are unclear in relation to degradation events during disease in the dentin-pulp complex. This study was undertaken to investigate the efects of dentin matrix components (DMCs) that are partially digested by matrix metalloproteinases (MMPs) in vitro and in vivo during wound healing of the dentin-pulp complex. DMCs were initially isolated from healthy dentin and treated with recombinant MMPs. Subsequently, their efects on the behaviour of primary pulp cells were investigated in vitro and in vivo. Digested DMCs modulated a range of pulp cell functions in vitro. In addition, DMCs partially digested with MMP-20 stimulated tertiary dentin formation in vivo, which exhibited a more regular tubular structure than that induced by treatment with other MMPs. Our results indicate that MMP-20 may be especially efective in stimulating wound healing of the dentin-pulp complex. When a tooth is damaged by caries and/or fracture, underlying pulp tissue can become exposed.
    [Show full text]
  • A Novel Neuregulin – Jagged1 Paracrine Loop in Breast Cancer Transendothelial Migration Ramon M
    Cabrera et al. Breast Cancer Research (2018) 20:24 https://doi.org/10.1186/s13058-018-0960-8 RESEARCH ARTICLE Open Access A novel neuregulin – jagged1 paracrine loop in breast cancer transendothelial migration Ramon M. Cabrera1, Serena P. H. Mao1, Chinmay R. Surve1, John S. Condeelis1,2,3 and Jeffrey E. Segall1,2* Abstract Background: The interaction of breast cancer cells with other cells in the tumor microenvironment plays an important role in metastasis. Invasion and intravasation, two critical steps in the metastatic process, are influenced by these interactions. Macrophages are of particular interest when it comes to studying tumor cell invasiveness. Previous studies have shown that there is paracrine loop signaling between breast cancer cells and macrophages involving colony stimulating factor 1 (CSF-1) produced by tumor cells and epidermal growth factor (EGF) production by macrophages. In this paper, we identify a novel paracrine loop between tumor cells and macrophages involving neuregulin (NRG1) and notch signaling. Methods: The aim of this study was to determine the role of NRG1, a ligand of the ErbB3 receptor, in macrophage stimulation of tumor cell transendothelial migration and intravasation. We used fluorescence-activated cell sorting (FACS) and western blot to determine ErbB3 and NRG1 expression, respectively. An in vitro transendothelial migration (iTEM) assay was used to examine the effects of short hairpin (sh)RNA targeting NRG1 in tumor cells and clustered regularly interspaced short palindromic repeats (CRISPR) knockout of jagged 1 (JAG1) in macrophages. Orthotopic xenograft injections in mice were used to confirm results in vivo. Results: In our system, macrophages were the primary cells showing expression of ErbB3, and a blocking antibody against ErbB3 resulted in a significant decrease in macrophage-induced transendothelial migration of breast cancer cells.
    [Show full text]
  • Epithelial–Mesenchymal Plasticity in Carcinoma Metastasis
    Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Epithelial–mesenchymal plasticity in carcinoma metastasis Jeff H. Tsai1 and Jing Yang1,2,3 1Department of Pharmacology, 2Department of Pediatrics, School of Medicine, University of California at San Diego, La Jolla, California 92093, USA Tumor metastasis is a multistep process by which tumor invade during developmental morphogenesis (Boyer cells disseminate from their primary site and form second- and Thiery 1993; Hay 1995). ary tumors at a distant site. Metastasis occurs through a Although epithelial cells convert into the mesenchy- series of steps: local invasion, intravasation, transport, mal state during developmental EMT, entering the EMT extravasation, and colonization. A developmental program program is not necessarily an irreversible commitment, termed epithelial–mesenchymal transition (EMT) has been as evident during kidney tubule formation. These epithe- shown to play a critical role in promoting metastasis in lial cells can activate a transitory EMT program and then epithelium-derived carcinoma. Recent experimental and undergo a reverse process called mesenchymal–epithelial clinical studies have improved our knowledge of this transition (MET) to continue their differentiation paths dynamic program and implicated EMT and its reverse (Thiery et al. 2009; Lim and Thiery 2012). In many instances, program, mesenchymal–epithelial transition (MET), in the identification of an epithelial versus a mesenchymal the metastatic process. Here, we review the functional state can be relatively fluid, and a partial EMT/MET requirement of EMT and/or MET during the individual frequently occurs to fulfill unique developmental tasks. steps of tumor metastasis and discuss the potential of These dynamic EMT/MET events highlight the enormous targeting this program when treating metastatic diseases.
    [Show full text]
  • Laminin Receptor on Human Breast Carcinoma Cells (Type IV Collagen/Basement Membrane/Metastasis) V
    Proc. NatL Acad. Sci. USA Vol. 80, pp. 444-448, January 1983 Cell Biology Laminin receptor on human breast carcinoma cells (type IV collagen/basement membrane/metastasis) V. P. TERRANOVA*, C. N. RAOt, T. KALEBICt, I. M. MARGULIESt, AND L. A. LIOTTAt *Laboratory of Developmental Biology and Anomalies, National Institute of Dental Research; and tLaboratory of Pathology, Section of Tumor Invasion and Metastases, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205 Communicated by Renato Dulbecco, October 20, 1982 ABSTRACT Human MCF-7 breast carcinoma cells possess a molecule that participate in the attachment of human breast receptor-like moiety on their surface that has a high binding af- carcinoma cells to type IV collagen. finity(Kd =2 nM) for laminin, aglycoprotein localized in basement The basement membrane is a specialized extracellular matrix membranes. Laminin preferentially stimulates (8-fold) MCF-7 composed of type IV collagen, glycoproteins such as laminin, cells to attach to type IV (basement membrane) collagen, whereas and proteoglycans. During the many stages of the metastatic fibronectin stimulates attachment only 2-fold for these cells on process (12), tumor cells encounter and traverse basement type I collagen. The attachment properties of two other human membranes. These tumor cells attach to the vascular basement breast carcinoma cell lines to type IV collagen were also studied. membrane in capillaries to both intravasation The attachment ofZR-75-1 cells was stimulated 4-fold by laminin prior and extra- and 5-fold by fibronectin, whereas T47-D cell attachment was vasation (13, 14). Thus, tumor cells that have the ability to pref- stimulated 2-fold by laminin and 7-fold by fibronectin.
    [Show full text]
  • Oriented Collagen Fibers Direct Tumor Cell Intravasation
    Oriented collagen fibers direct tumor cell intravasation Weijing Hana, Shaohua Chenb, Wei Yuanc, Qihui Fana, Jianxiang Tianb, Xiaochen Wanga, Longqing Chend, Xixiang Zhange, Weili Weie, Ruchuan Liuf, Junle Quc, Yang Jiaob, Robert H. Austing,c,1, and Liyu Liuf,a,1 aKey Laboratory of Soft Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, China 100190; bMaterials Science and Engineering, Arizona State University, Tempe, AZ 85281; cKey Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen, China 518060; dDivision of Physical Science and Engineering, King Abdullah University of Science & Technology, Thuwal, Saudi Arabia 23955-6900; eInnovative Drug Research Center, Chongqing University, Chongqing, China 401331; fCollege of Physics, Chongqing University, Chongqing, China 401331; and gDepartment of Physics, Princeton University, Princeton, NJ 08544 Contributed by Robert H. Austin, July 28, 2016 (sent for review November 17, 2015; reviewed by Pascal Silberzan, Denis Wirtz, and Clare C. Yu) In this work, we constructed a Collagen I–Matrigel composite extra- surrounding the tumor lesion are parallel to the tumor boundary, cellular matrix (ECM). The composite ECM was used to determine where the collagen is located but without obviously specific the influence of the local collagen fiber orientation on the collective alignment (termed TACS-1) (12). Fig. 1 B, 1–3 represents in- intravasation ability of tumor cells. We found that the local fiber vasive ductal carcinoma at grade III. In this case, after cell de- alignment enhanced cell–ECM interactions. Specifically, metastatic velopment, collagen fiber (blue) and tumor cells (gray) have MDA-MB-231 breast cancer cells followed the local fiber alignment more mixed forms.
    [Show full text]
  • Oriented Collagen Fibers Direct Tumor Cell Intravasation
    Oriented collagen fibers direct tumor cell intravasation Weijing Hana, Shaohua Chenb, Wei Yuanc, Qihui Fana, Jianxiang Tianb, Xiaochen Wanga, Longqing Chend, Xixiang Zhange, Weili Weie, Ruchuan Liuf, Junle Quc, Yang Jiaob, Robert H. Austing,c,1, and Liyu Liuf,a,1 aKey Laboratory of Soft Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, China 100190; bMaterials Science and Engineering, Arizona State University, Tempe, AZ 85281; cKey Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen, China 518060; dDivision of Physical Science and Engineering, King Abdullah University of Science & Technology, Thuwal, Saudi Arabia 23955-6900; eInnovative Drug Research Center, Chongqing University, Chongqing, China 401331; fCollege of Physics, Chongqing University, Chongqing, China 401331; and gDepartment of Physics, Princeton University, Princeton, NJ 08544 Contributed by Robert H. Austin, July 28, 2016 (sent for review November 17, 2015; reviewed by Pascal Silberzan, Denis Wirtz, and Clare C. Yu) In this work, we constructed a Collagen I–Matrigel composite extra- surrounding the tumor lesion are parallel to the tumor boundary, cellular matrix (ECM). The composite ECM was used to determine where the collagen is located but without obviously specific the influence of the local collagen fiber orientation on the collective alignment (termed TACS-1) (12). Fig. 1 B, 1–3 represents in- intravasation ability of tumor cells. We found that the local fiber vasive ductal carcinoma at grade III. In this case, after cell de- alignment enhanced cell–ECM interactions. Specifically, metastatic velopment, collagen fiber (blue) and tumor cells (gray) have MDA-MB-231 breast cancer cells followed the local fiber alignment more mixed forms.
    [Show full text]
  • Myosin Light Chain Kinase Mediates Transcellular Intravasation of Breast Cancer Cells Through the Underlying Endothelial Cells: a Three-Dimensional FRET Study
    Research Article 431 Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: a three-dimensional FRET study Satya Khuon1,2, Luke Liang1, Robert W. Dettman3, Peter H. S. Sporn4,5, Robert B. Wysolmerski6,7 and Teng-Leong Chew1,2,* 1Cell Imaging Facility, 2Department of Cell and Molecular Biology, 3Department of Pediatrics and 4Division of Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA 5Jesse Brown Veterans Affairs Medical Center, Chicago, IL 60612, USA 6Department of Neurobiology and Anatomy and 7The Mary Babb Randolph Cancer Center, West Virginia University School of Medicine, Morgantown, WV 26506, USA *Author for correspondence ([email protected]) Accepted 18 November 2009 Journal of Cell Science 123, 431-440 Published by The Company of Biologists 2010 doi:10.1242/jcs.053793 Summary The transient and localized signaling events between invasive breast cancer cells and the underlying endothelial cells have remained poorly characterized. We report a novel approach integrating vascular engineering with three-dimensional time-lapse fluorescence resonance energy transfer (FRET) imaging to dissect how endothelial myosin light chain kinase (MLCK) is modulated during tumor intravasation. We show that tumor transendothelial migration occurs via both paracellular (i.e. through cell-cell junctions) and transcellular (i.e. through individual endothelial cells) routes. Endothelial MLCK is activated at the invasion site, leading to regional diphosphorylation of myosin-II regulatory light chain (RLC) and myosin contraction. Blocking endothelial RLC diphosphorylation blunts tumor transcellular, but not paracellular, invasion. Our results implicate an important role for endothelial myosin-II function in tumor intravasation.
    [Show full text]
  • Immune Cell Promotion of Metastasis
    REVIEWS Immune cell promotion of metastasis Takanori Kitamura1, Bin-Zhi Qian1 and Jeffrey W. Pollard1,2 Abstract | Metastatic disease is the major cause of death from cancer, and immunotherapy and chemotherapy have had limited success in reversing its progression. Data from mouse models suggest that the recruitment of immunosuppressive cells to tumours protects metastatic cancer cells from surveillance by killer cells, which nullifies the effects of immunotherapy and thus establishes metastasis. Furthermore, in most cases, tumour- infiltrating immune cells differentiate into cells that promote each step of the metastatic cascade and thus are novel targets for therapy. In this Review, we describe how tumour- infiltrating immune cells contribute to the metastatic cascade and we discuss potential therapeutic strategies to target these cells. Metastasis Cancer progression ends in metastatic disease, which is which can influence the growth of other less aggressive 7 The spread of malignant the major cause of cancer death. For metastasis to occur primary tumours . The tumour-driven systemic pro- tumour cells from the from solid malignancies, tumour cells need to undergo cesses also prepare distant sites to become pre-metastatic primary tumour site to a process that is referred to as the metastatic cascade niches, thereby enhancing metastatic efficiency7. distant organs (through the (FIG. 1). At the primary site, tumour cells escape from These systemic enhancements of metastasis involve, at lymphatic system or the blood), in which they grow the antitumour immune response and remotely prepare least partly, myeloid cells that facilitate the escape of expansively to develop deadly the environment of the future metastatic site (pre- circulating metastatic cells from immune detection.
    [Show full text]